Organon & Co

Healthcare · Drug Manufacturers - General

13.80$ +0.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 13,178 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OGN
Line item	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	10,109	9,642	10,908	11,335	10,681	10,597	10,614	10,437	10,955	10,763	10,979	11,012	12,058	11,891	12,154	12,752	13,101	13,156	13,500	13,552	12,867	12,996	13,178
Current Assets	319	–	–	3,567	2,977	3,911	4,329	3,760	3,719	3,774	3,592	3,931	3,780	3,958	4,050	4,508	4,196	4,509	4,756	4,348	4,371	4,618	4,700	4,352	4,932	5,111
Cash	-319	–	–	12	141	730	1,008	737	694	545	499	706	459	326	414	693	575	704	763	675	547	599	672	574	1,116	1,132
Cash & Short-Term Investments	319	–	–	12	141	730	1,008	737	694	545	499	706	459	326	414	693	575	704	763	675	547	599	672	574	1,116	1,132
Receivables	–	–	–	1,405	1,010	1,507	1,510	1,512	1,348	1,499	1,450	1,606	1,465	1,683	1,656	1,857	1,556	1,652	1,729	1,491	1,467	1,511	1,521	1,433	1,385	1,492
Inventory	–	–	–	913	924	909	918	915	946	950	879	1,003	1,121	1,199	1,186	1,315	1,263	1,287	1,383	1,321	1,362	1,454	1,488	1,406	1,373	1,351
Property, Plant & Equipment	–	–	–	–	986	1,269	967	973	970	952	906	1,233	1,055	1,110	1,096	–	–	–	1,204	1,325	1,197	1,266	1,290	1,458	–	–
Goodwill	–	–	–	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,603	4,680	4,680	4,680	4,680	4,153	4,153	4,153
Intangible Assets	–	–	–	503	482	711	683	651	665	638	670	649	621	592	561	533	718	684	763	1,414	1,417	1,362	1,340	1,130	1,099	1,112
Total Liabilities	–	–	–	4,623	4,920	12,842	12,953	12,189	11,847	11,751	11,503	11,847	11,500	11,534	11,601	12,128	11,843	12,010	12,259	12,629	12,614	12,767	12,646	12,115	12,093	12,172
Current Liabilities	–	–	–	2,673	2,875	2,975	3,129	2,597	2,306	2,396	2,328	2,512	2,346	2,387	2,491	2,918	2,545	2,755	2,790	2,718	2,615	2,796	2,679	2,390	2,500	2,616
Short-Term Debt	–	–	–	8.0	1,520	105	106	55	9.0	9.0	8.0	57	8.0	8.0	8.0	55	9.0	9.0	10	64	20	115	45	56	16	74
Accounts Payable	–	–	–	259	264	1,812	1,673	1,382	1,081	1,130	1,004	1,132	996	1,115	1,067	1,314	955	1,243	1,092	1,153	1,006	1,067	1,074	952	983	1,051
Long-Term Debt	–	–	–	–	–	9,309	9,259	9,125	9,085	8,884	8,691	8,905	8,703	8,722	8,646	8,751	8,705	8,647	8,739	8,860	8,936	8,781	8,783	8,628	8,553	8,479
Shareholders' Equity	7,035	–	–	5,486	4,722	-1,934	-1,618	-1,508	-1,250	-1,137	-1,066	-892	-737	-555	-589	-70	48	144	493	472	542	733	906	752	903	1,006
Retained Earnings	–	–	–	-219	–	-1,473	-1,128	-998	-724	-551	-383	-331	-206	-25	-16	443	573	690	975	1,010	1,026	1,163	1,318	1,109	1,253	1,352
Shares Outstanding	253	253	253	253	253	254	254	255	255	255	255	255	256	256	256	257	258	259	260	260	261	260	261	260	263	270

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings